274 related articles for article (PubMed ID: 12242729)
1. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice.
Zhou JR; Yu L; Mai Z; Blackburn GL
Int J Cancer; 2004 Jan; 108(1):8-14. PubMed ID: 14618609
[TBL] [Abstract][Full Text] [Related]
3. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
[TBL] [Abstract][Full Text] [Related]
4. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.
Zhou JR; Yu L; Zhong Y; Blackburn GL
J Nutr; 2003 Feb; 133(2):516-21. PubMed ID: 12566493
[TBL] [Abstract][Full Text] [Related]
5. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
Singh AV; Franke AA; Blackburn GL; Zhou JR
Cancer Res; 2006 Feb; 66(3):1851-8. PubMed ID: 16452247
[TBL] [Abstract][Full Text] [Related]
6. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
7. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones.
Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D
Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
9. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
[TBL] [Abstract][Full Text] [Related]
10. 17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.
Qiao Y; Zhang ZK; Cai LQ; Tan C; Imperato-McGinley JL; Zhu YS
Prostate; 2007 Dec; 67(16):1719-28. PubMed ID: 17879940
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
Zaidman BZ; Wasser SP; Nevo E; Mahajna J
Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330
[TBL] [Abstract][Full Text] [Related]
12. Genistein and daidzein downregulate prostate androgen-regulated transcript-1 (PART-1) gene expression induced by dihydrotestosterone in human prostate LNCaP cancer cells.
Yu L; Blackburn GL; Zhou JR
J Nutr; 2003 Feb; 133(2):389-92. PubMed ID: 12566472
[TBL] [Abstract][Full Text] [Related]
13. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
[TBL] [Abstract][Full Text] [Related]
16. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
Mori A; Lehmann S; O'Kelly J; Kumagai T; Desmond JC; Pervan M; McBride WH; Kizaki M; Koeffler HP
Cancer Res; 2006 Mar; 66(6):3222-9. PubMed ID: 16540674
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Serafin AM; Akudugu JM; Bohm L
Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.
Rice L; Handayani R; Cui Y; Medrano T; Samedi V; Baker H; Szabo NJ; Rosser CJ; Goodison S; Shiverick KT
J Nutr; 2007 Apr; 137(4):964-72. PubMed ID: 17374662
[TBL] [Abstract][Full Text] [Related]
20. Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer.
Kampa M; Theodoropoulou K; Mavromati F; Pelekanou V; Notas G; Lagoudaki ED; Nifli AP; Morel-Salmi C; Stathopoulos EN; Vercauteren J; Castanas E
J Pharmacol Exp Ther; 2011 Apr; 337(1):24-32. PubMed ID: 21205921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
